Developments on Cancer Therapy through Oncolytic Virotherapy
Publish place: Medbiotech Journal، Vol: 2، Issue: 3
Publish Year: 1397
نوع سند: مقاله ژورنالی
زبان: English
View: 231
This Paper With 8 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_MBT-2-3_006
تاریخ نمایه سازی: 10 خرداد 1399
Abstract:
Cancer is a complex disease and is difficult to treat. Until the early twentieth century, it was treated by surgical removal which later on was combined with chemotherapy, radiotherapy and immunotherapy. However, advances in molecular biology and genetics lead to the establishment of virotherapy. The genetic modification of oncolytic viruses has improved their tumor specificity, targeted delivery and increased efficacy, leading to the development of new weapons for the war against cancer especially in those cancer patients in which tumor is inoperable. In this review, we describe the basis of oncolyticvirotherapy and how the genetically modified tumor-specific viruses are developed. Utility of oncolytic virotherapy to treat cancer, clinical trials and their success rate are also discussed. We conclude with current and future challenges in oncolyticvirotherapy and the safety concerns raised by the trials conducted so far.
Keywords:
Authors
Sadia Mehmood
Department of Biochemistry, FMH Medical & Dental College, Lahore, Pakistan
Muhammad Qazi
Department of Biochemistry, FMH Medical & Dental College, Lahore, Pakistan